References
- 1. Fanping M, Xiaojuang Y, Xuemei M, Xiao-Dong G, Bo J, Hanwei Li. Assesment of the value of serum cholinesterase as a liver function test for cirrhotic patients. Biomedical reports. Beijing: Pathological Diagnosis and Research Center, 2013, pp. 265-268.10.3892/br.2013.60391707224648933
- 2. RS, Weisinger. Laboratory tests in liver disease and approach to the patient with abnormal test. Goldman L. and Bennett. In Cecil Textbook of Medicine. JC(eds.) 21st edition. Philadelphia: WB Saunders, 2000, pp. 775-777.
- 3. Zhou X., Tu ZG. Clinical Biological Chemical and Biological Chemical Inspection 3rd edition. Beijing: People’s Medical Publishing House, 2003, pp. 325-328.
- 4. KariyoneK, Shimatani Y, Kurihara T, Fujita Y, Uesugi M. Establishing indicators for Cholinergic crisis. Rinso: Byori, 2010, pp. 972-978.
- 5. Lu Z, Zhong NS. Internal Medicine. 7th edition. Beijing: People’s Medical Publishing House, 2008. p. 453.
- 6. Zou Z, Xin S, Li B. Relationship between cholinesterase, prothrombin activity and albumin and the pathology of the liver. Beijing: Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 2001.
- 7. Sinha SN, Keresztes-Nagy S, Frankfater A. Studies on the distribution of cholinesterase: Activity in the human and dog heart. s.l.: Pediatr Res 10, 2006.10.1203/00006450-197608000-00012
- 8. Kondo M, Hada T, Fukui T. Enzyme-linked immunosorbent assay (ELISA) for aleuria aurantia lactin- reactive serum cholinesterase to diferentiate liver cirrhosis and chronoc hepatitis. s.l.: Clin Chim Acta 243, 1995, pp. 1-9.10.1016/0009-8981(95)06146-08747509
- 9. AI, Ogunkeye OO and Roluga. Serum cholinesterase activity helpsto distinguish between liver disease and non-liver disease in liver function tests. Pathophysiology. 2006, pp. 91-93.10.1016/j.pathophys.2006.01.00216530396
- 10. B, McArdle. The serum cholinesterase in jaundice and diseases of the liver. s.l.: Quart J Med, 1940, p. 107.
- 11. Association of Infectious and Parasitic Epidemiology Branch of Learning Branch of Liver Disease: viral hepatitis prevention and treatment plan. s.l.: China J Inter Med, 2001, pp. 62-68.
- 12. Wang I, Gao XI, Bay YZ. Patients with cirrhosis serum cholinesterase clinical research. s.l.: Chin J Med Guide, 2005, p. 68.
- 13. Gu YJ, Zhong YB. Cholinesterase determination of evaluation of patients with liver cirrhosis of the liver reserves significance. s.l.: Chin J Med Guide, 2010, pp. 649-650.
- 14. Prakash R, Mullen KD. Mechanics, diagnosis and management of hepatic encephalopathy. s.l.: Nat Rev Gastroenterol Hepatol, 2010, pp. 515-525.10.1038/nrgastro.2010.11620703237
- 15. Chromy V, Svachova L, Novosad L. Albumin based or albumin-linked calibration cause o positive bias in serum proteins assayed by the buiret method. s.l.: Clin Chem Lab Med, 2009, pp. 91-101.10.1515/CCLM.2009.01119117409
- 16. Garg H, Kumar A, Garg V, Sharma P, Sharma BC, Sarina SK. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. s.l.: Dig Liver Dis, 2012, pp. 166-171.10.1016/j.dld.2011.08.02921978580
- 17. D, Vincent. Transaminases, or nithinecarbamyl transferase, arginase, cholinesterase, etarylesterase. Lyon: Lyon Med 232, 1974, pp. 267-273.